Simulations Plus (SLP) Announces Collaboration Agreement with Top-5 Pharma Company
- RenaissanceRe (RNR) to Acquire Platinum Underwriters (PTP) in $1.9B Deal
- Unusual 11 Mid-Day Movers 11/24: (BMRN) (CIMT) (SYN) Higher; (CANF) (GALE) (BIND) Lower
- Carl Icahn: Do Yourself a Favor and Follow Me on Twitter (AAPL)
- U.S. Defense Secretary Hagel Said to Step Down Amid Pressure
- Sterne Agee Lists Six Top Retail 'Stock'ing Stuffers' Into the Holiday Season (ULTA) (COST) (DECK) (more...)
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it has signed a collaboration agreement with a top-5 pharmaceutical company to extend and enhance its oral cavity dosing model within its industry gold standard GastroPlus™ simulation software program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Netflix (NFLX) CEO: LatAm Not Yet Profitable; Company Investing to Produce More Content
- Simulations Plus to Present at the LD MICRO Conference in Los Angeles on December 3
- Endo Int\'l (ENDP) Acquires Natesto Gel Rights from Trimel BioPharma
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!